Oral delivery of low molecular weight heparin microspheres prepared using biodegradable polymer matrix system

References

• Abildgaard U, Norrheim L, Larsen AE, Nesvold A, Sandset PM, Odegaard OR. Monitoring therapy with LMW heparin: a comparison of three chromogenic substrate assays and the Heptest clotting assays. Haemostasis 1990; 20: 193–203
   PubMedGoogle Scholar
• Arya N, Chakraborty S, Dube N, Katti DS. Electrospraying: A facile technique for synthesis of chitosan-based micro/nanospheres for drug delivery applications. J Biomed Mater Res B Appl Biomater 2008, Epub ahead of print (Pubmed ID 18386845)
   Google Scholar
• Boneu B. Low molecular weight heparin therapy: is monitoring needed?. Thromb Haemost 1994; 72: 330–334
   PubMed Web of Science ®Google Scholar
• Camenisch G, Alsenz J, van de Waterbeemd H, Folkers G. Estimation of permeability by passive diffusion through caco-2 cell monolayers using the drugs’ lipophilicity and molecular weight. Eur J Pharm Sci 1998; 6: 317–324
   PubMed Web of Science ®Google Scholar
• Charbonnier BA, Fiessinger JN, Banga JD, Wenzel E, d’Azemar P, Sagnard L. Comparison of a once daily with a twice daily subcutaneous low molecular weight heparin regimen in the treatment of deep vein thrombosis. Fraxodi group. Thromb Haemost 1998; 79: 897–901
   PubMed Web of Science ®Google Scholar
• Costabel M, Vallejo DF, Grigera JR. Electrostatic recognition between enzyme and inhibitor: Interaction between papain and leupeptin. Arch Biochem Biophys 2001; 394: 161–166
   PubMed Web of Science ®Google Scholar
• Dal Pozzo A, Acquasaliente M, Geron MR, Andriuoli G. New heparin complexes active by intestinal absorption: I-multiple ion pairs with basic organic compounds. Thromb Res 1989; 56: 119–124
   PubMed Web of Science ®Google Scholar
• Dass CR, Su T. Particle-mediated intravascular delivery of oligonucleotides to tumors: Associated biology and lessons from genotherapy. Drug Deliv 2001; 8: 191–213
   PubMed Web of Science ®Google Scholar
• Devineni D, Ezekwudo D, Palaniappan R. Formulation of maltodextrin entrapped in polycaprolactone microparticles for protein and vaccine delivery: Effect of size determining formulation process variables of microparticles on the hydrodynamic diameter of BSA. J Microencapsulation 2007; 24: 358–370
   PubMed Web of Science ®Google Scholar
• Donovan MD, Flynn GL, Amidon GL. Absorption of polyethylene glycols 600 through 2000: The molecular weight dependence of gastrointestinal and nasal absorption. Pharm Res 1990; 7: 863–868
   PubMed Web of Science ®Google Scholar
• Fey MF, Lang M, Furlan M, Beck EA. Monitoring of heparin therapy with the activated partial thromboplastin time and chromogenic substrate assays. Thromb Haemost 1987; 58: 853–855
   PubMed Web of Science ®Google Scholar
• Friberger P, Krig E, Eriksson-Skoog L, Svensson S, Isacson C. Coacute heparin: a new simple monotest for monitoring heparin treatment. Semin Thromb Hemost 1993; 19(Suppl 1)86–89
   PubMed Web of Science ®Google Scholar
• Frydman A. Low-molecular-weight heparins: An overview of their pharmacodynamics, pharmacokinetics and metabolism in humans. Haemostasis 1996; 26(Suppl 2)24–38
   PubMedGoogle Scholar
• Grabovac V, Bernkop-Schnürch A. Improvement of the intestinal membrane permeability of low molecular weight heparin by complexation with stem bromelain. Int J Pharm 2006; 326: 153–159
   PubMed Web of Science ®Google Scholar
• Grabovac V, Schmitz T, Ger F, Bernkop S, Rch A. Papain: An effective permeation enhancer for orally administered low molecular weight heparin. Pharm Res 2007; 24: 1001–1006
   PubMed Web of Science ®Google Scholar
• Harrison L, McGinnis J, Crowther M, Ginsberg J, Hirsh J. Assessment of outpatient treatment of deep-vein thrombosis with low-molecular-weight heparin. Arch Intern Med 1998; 158: 2001–2003
   PubMedGoogle Scholar
• Haswani DK, Nettey H, Oettinger C, D'Souza MJ. Formulation, characterization and pharmacokinetic evaluation of gentamicin sulphate loaded albumin microspheres. J Microencapsulation 2006; 23: 875–886
   PubMed Web of Science ®Google Scholar
• Hirsh J, Warkentin TE, Shaughnessy SG, Anand SS, Halperin JL, Raschke R, et al. Heparin and low-molecular-weight heparin: Mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety. Chest 2001; 119(1 Suppl)64S–94S
   PubMed Web of Science ®Google Scholar
• Hoffart V, Ubrich N, Simonin C, Babak V, Vigneron C, Hoffman M, et al. Low molecular weight heparin-loaded polymeric nanoparticles: Formulation, characterization, and release characteristics. Drug Dev Ind Pharm 2002; 28: 1091–1099
   PubMed Web of Science ®Google Scholar
• Hyers TM, Hull RD, Weg JG. Antithrombotic therapy for venous thromboembolic disease. Chest 1986; 89(2 Suppl)26S–35S
   Google Scholar
• Jandik KA, Kruep D, Cartier M, Linhardt RJ. Accelerated stability studies of heparin. J Pharm Sci 1996; 85: 45–51
   PubMed Web of Science ®Google Scholar
• Jiao Y, Ubrich N, Hoffart V, Marchand-Arvier M, Vigneron C, Hoffman M, et al. Anticoagulant activity of heparin following oral administration of heparin-loaded microparticles in rabbits. J Pharm Sci 2002; 91: 760–768
   PubMed Web of Science ®Google Scholar
• Lee VHL, Yamamoto A. Penetration and enzymatic barriers to peptide and protein absorption. Adv Drug Deliv Rev 1989; 4: 171–207
   Google Scholar
• Lensing AW, Prins MH, Davidson BL, Hirsh J. Treatment of deep venous thrombosis with low-molecular-weight heparins. A meta-analysis. Arch Intern Med 1995; 155: 601–607
   PubMed Web of Science ®Google Scholar
• Lin Z, Cui S, Zhang H, Chen Q, Yang B, Su X, et al. Studies on quantum dots synthesized in aqueous solution for biological labeling via electrostatic interaction. Anal Biochem 2003; 319: 239–243
   PubMed Web of Science ®Google Scholar
• Michnik A, Michalik K, Kluczewska A, Drzazga Z. Comparitive dsc study of human and bovine serum albumin. J Thermal Anal Calorimetry 2006; 84: 113–117
   Web of Science ®Google Scholar
• Pamujula S, Graves RA, Freeman T, Srinivasan V, Bostanian LA, Kishore V, et al. Oral delivery of spray dried plga/amifostine nanoparticles. J Pharm Pharmacol 2004; 56: 1119–1125
   PubMed Web of Science ®Google Scholar
• Ross BP, Toth I. Gastrointestinal absorption of heparin by lipidization or coadministration with penetration enhancers. Curr Drug Deliv 2005; 2: 277–287
   PubMedGoogle Scholar
• Sacchetti M, Van Oor MM. Inhalation aerosols—physical and biological basis for therapy. Marcel Dekker, USA 1996
   Google Scholar
• Salzman EW, Harris WH. Prevention of venous thromboembolism in orthopaedic patients. J Bone Joint Surg Am 1976; 58: 903–913
   PubMed Web of Science ®Google Scholar
• Sankalia MG, Mashru RC, Sankalia JM, Sutariya VB. Papain entrapment in alginate beads for stability improvement and site-specific delivery: Physicochemical characterization and factorial optimization using neural network modeling. AAPS PharmSciTech 2005; 6: E209–E222
   PubMed Web of Science ®Google Scholar
• Tew CJ, Lane DA, Thompson E, Ireland H, Curtis JR. Relationship between ex vivo anti-proteinase (factor Xa and thrombin) assays and in vivo anticoagulant effect of very low molecular weight heparin, CY222. Br J Haematol 1988; 70: 335–340
   PubMed Web of Science ®Google Scholar
• Todd CJ, Freeman CJ, Camilleri-Ferrante C, Palmer CR, Hyder A, Laxton CE, et al. Differences in mortality after fracture of hip: The East Anglian audit. BMJ 1995; 310: 904–908
   PubMed Web of Science ®Google Scholar
• Walenga JM, Hoppensteadt D, Fareed J. Laboratory monitoring of the clinical effects of low molecular weight heparins. Thromb Res Suppl 1991; 14: 49–62
   PubMed Web of Science ®Google Scholar
• Warda M, Gouda EM, Toida T, Chi L, Linhardt RJ. Isolation and characterization of raw heparin from dromedary intestine: evaluation of a new source of pharmaceutical heparin. Comp Biochem Physiol C Toxicol Pharmacol 2003; 136: 357–365
   PubMed Web of Science ®Google Scholar
• Zidan AS, Sammour OA, Hammad MA, Megrab NA, Hussain MD, Khan MA, et al. Formulation of anastrozole microparticles as biodegradable anticancer drug carriers. AAPS PharmSciTech 2006; 7: 61
   PubMed Web of Science ®Google Scholar